TIDMAGR

RNS Number : 0769S

Assura PLC

12 July 2022

12 July 2022

Assura plc

Additional Listing

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that 974,245 New Ordinary Shares (the "New Shares") have been issued to the Assura plc Employee Benefit Trust in order to satisfy the awards pursuant to the 2019 Performance Share Plan (591,051) and also restricted share awards pursuant to the Performance Share Plan (383,194).

Application has therefore been made for the admission of the New Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 13 July 2022.

Following the allotment of the New Shares (and including the scrip dividend shares also to be issued on 13 July 2022 as announced 11 July 2022), it is expected that the total number of shares in issue will be 2,959,198,708 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 2,959,198,708.

- ENDS -

For more information, please contact:

 
 
    Assura plc                            Tel: 01925 945354 
  Orla Ball, Company Secretary          Email: Investor@assura.co.uk 
   David Purcell, Investor Relations 
   Director 
  FGS Global                            Tel: 0207 251 3801 
   Gordon Simpson                        Email: Assura@fgsglobal.com 
   James Thompson

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which almost seven million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2022, Assura's portfolio was valued at GBP2,752 million.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

* EPRA is a registered trademark of the European Public Real Estate Association

Assura plc LEI code: 21380026T19N2Y52XF72

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ALSGPUPUMUPPGQG

(END) Dow Jones Newswires

July 12, 2022 02:00 ET (06:00 GMT)

Assura (LSE:AGR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Assura Charts.
Assura (LSE:AGR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Assura Charts.